GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 19.40
-0.30 (-1.52%)
Apr 20, 2026, 1:22 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 1.12 billion as of April 20, 2026. Its market cap has decreased by -26.01% in one year.
Market Cap
1.12B
Enterprise Value
1.06B
Revenue
232.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.40
Market Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.12B, a decrease of -11.97%. That is a compound annual growth rate of -0.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.13B | 4.06% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.41B |
| Abnova (Taiwan) | 1.36B |
| Enimmune | 1.34B |
| Great Novel Therapeutics Biotech & Medicals | 1.33B |
| Holy Stone Healthcare | 1.24B |
| Meribank Biotech | 1.16B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.03B |